Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Elevance Health Inc

Healthcare US ELV

418.15USD
2.62(0.63%)

Last update at 2026-06-08T20:00:00Z

Day Range

410.50421.00
LowHigh

52 Week Range

269.17420.28
LowHigh

Fundamentals

  • Previous Close 415.53
  • Market Cap72415.40M
  • Volume1771393
  • P/E Ratio13.02
  • Dividend Yield2.14%
  • EBITDA9040.00M
  • Revenue TTM199126.01M
  • Revenue Per Share TTM888.96
  • Gross Profit TTM 50903.00M
  • Diluted EPS TTM25.20

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 6710.00M 7904.00M 7715.00M 7769.00M 7925.00M
Minority interest 1.00M 9.00M -41.00000M 6.00M 9.00M
Net income 5662.00M 5980.00M 5987.00M 6025.00M 6104.00M
Selling general administrative - - - 7453.00M 6.91M
Selling and marketing expenses - - - 10233.00M -
Gross profit 50902.00M 49243.00M 47010.00M 143560.00M 127744.00M
Reconciled depreciation 1546.00M 1393.00M 1794.00M 1675.00M 1302.00M
Ebit 8112.00M 9089.00M 8745.00M 7769.00M 7925.00M
Ebitda 9658.00M 10482.00M 10490.00M 9444.00M 9227.00M
Depreciation and amortization 1546.00M 1393.00M 1745.00M 1675.00M 1302.00M
Non operating income net other - - - - -
Operating income 8112.00M 8888.00M 8745.00M 7769.00M 7925.00M
Other operating expenses 191013.00M 167922.00M 162595.00M 148826.00M 130714.00M
Interest expense 1402.00M 1185.00M 1030.00M 851.00M 798.00M
Tax provision 1049.00M 1933.00M 1760.00M 1750.00M 1830.00M
Interest income 1402.00M 1185.00M 1030.00M 851.00M 798.00M
Net interest income -1402.00000M -1185.00000M -1000.00000M -851.00000M -798.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1049.00M 1933.00M 1724.00M 1750.00M 1830.00M
Total revenue 199125.00M 176810.00M 171340.00M 156595.00M 138639.00M
Total operating expenses 42790.00M 40355.00M 38265.00M 17686.00M 15914.00M
Cost of revenue 148223.00M 127567.00M 124330.00M 13035.00M 10895.00M
Total other income expense net -1402.00000M -984.00000M -1030.00000M -851.00000M 12648.00M
Discontinued operations - - - - -
Net income from continuing ops 5661.00M 5971.00M 6168.00M 6019.00M 6095.00M
Net income applicable to common shares 5662.00M 5980.00M 5987.00M 6025.00M 6104.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 121494.00M 116889.00M 108928.00M 102772.00M 97307.00M
Intangible assets 11200.00M 12094.00M 10273.00M 10315.00M 10615.00M
Earning assets - - - - -
Other current assets -32191.00000M -52560.00000M -54005.00000M 43567.00M 38483.00M
Total liab 77468.00M 75463.00M 69523.00M 66378.00M 61179.00M
Total stockholder equity 43882.00M 41315.00M 39306.00M 36307.00M 36060.00M
Deferred long term liab - - - 2034.00M 2805.00M
Other current liab 22702.00M -26195.00000M -26297.00000M 16188.00M -21515.00000M
Common stock 2.00M 2.00M 2.00M 2.00M 2.00M
Capital stock 2.00M 2.00M 2.00M 2.00M 2.00M
Retained earnings 35393.00M 33549.00M 31749.00M 29724.00M 27088.00M
Other liab - - - 3582.00M 5137.00M
Good will 28344.00M 28277.00M 25317.00M 24383.00M 24228.00M
Other assets 121494.00M 116889.00M 108928.00M 1852.00M -14822.00000M
Cash 9491.00M 8288.00M 6526.00M 7387.00M 4880.00M
Cash and equivalents 9491.00M 8288.00M 6526.00M 7387.00M 4880.00M
Total current liabilities 19957.00M 19421.00M 19551.00M 39696.00M 21515.00M
Current deferred revenue 1493.00M 1508.00M 1402.00M 1112.00M 1153.00M
Net debt 23744.00M 24413.00M 20128.00M 16727.00M 18151.00M
Short term debt 1380.00M 2167.00M 2038.00M 1765.00M 1874.00M
Short long term debt 1249.00M 2014.00M 1874.00M 1765.00M 1874.00M
Short long term debt total 33235.00M 32701.00M 26654.00M 24114.00M 23031.00M
Other stockholder equity 8938.00M 8911.00M 8868.00M 9084.00M 9148.00M
Property plant equipment 4679.00M 5219.00M 4943.00M 4316.00M 3919.00M
Total current assets 24726.00M 21343.00M 18986.00M 55617.00M 44587.00M
Long term investments 27745.00M 27428.00M 30719.00M 27657.00M 28780.00M
Net tangible assets - - - 1609.00M 1217.00M
Short term investments 25884.00M 25201.00M 29614.00M 25952.00M 26267.00M
Net receivables 15235.00M 13055.00M 12460.00M 16044.00M 13440.00M
Long term debt 30797.00M 29218.00M 23246.00M 22349.00M 21157.00M
Inventory - - -46332.00000M -11381.00000M -38483.00000M
Accounts payable 17084.00M 15746.00M 16111.00M 20631.00M 18488.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 87.00M 68.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -451.00000M -1147.00000M -1313.00000M -2503.00000M -178.00000M
Additional paid in capital - - - - -
Common stock total equity - - - 2.00M 2.00M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 29724.00M 27088.00M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 13211.00M 12573.00M 12355.00M -19829.00000M -67542.00000M
Deferred long term asset charges - - - - -
Non current assets total 96768.00M 95546.00M 89942.00M 47155.00M 67542.00M
Capital lease obligations - - - - -
Long term debt total 30797.00M 29218.00M 23246.00M 22349.00M 21157.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 69.00M -5167.00000M -4254.00000M -4560.00000M -4056.00000M
Change to liabilities - - - 2698.00M 606.00M
Total cashflows from investing activities -1344.00000M -5167.00000M -5572.00000M -4560.00000M -9638.00000M
Net borrowings 2327.00M 5562.00M 739.00M 1795.00M 3675.00M
Total cash from financing activities -1738.00000M 1193.00M -3349.00000M -1318.00000M 423.00M
Change to operating activities - - - 2319.00M 2176.00M
Net income 5661.00M 5971.00M 5987.00M 6019.00M 6095.00M
Change in cash 1203.00M 1762.00M -861.00000M 2507.00M -861.00000M
Begin period cash flow 8288.00M 6526.00M 7387.00M 4880.00M 5741.00M
End period cash flow 9491.00M 8288.00M 6526.00M 7387.00M 4880.00M
Total cash from operating activities 4290.00M 5808.00M 8061.00M 8399.00M 8364.00M
Issuance of capital stock - - - - -
Depreciation 1546.00M 1393.00M 1745.00M 1675.00M 1302.00M
Other cashflows from investing activities -385.00000M -51.00000M -24.00000M -3408.00000M -1019.00000M
Dividends paid 1529.00M 1508.00M 1395.00M -1229.00000M -1104.00000M
Change to inventory - - 1762.00M - -
Change to account receivables -2526.00000M -683.00000M -1762.00000M -2510.00000M -2138.00000M
Sale purchase of stock -2605.00000M -2900.00000M -2676.00000M -2316.00000M -1900.00000M
Other cashflows from financing activities 69.00M 39.00M -17.00000M 5598.00M -451.00000M
Change to netincome - - - -87.00000M 174.00M
Capital expenditures 1116.00M 1256.00M 1296.00M 1152.00M 1087.00M
Change receivables - - - -2510.00000M -2138.00000M
Cash flows other operating - - - 604.00M -260.00000M
Exchange rate changes - - - - -10.00000M
Cash and cash equivalents changes - - - 2521.00M -861.00000M
Change in working capital -3277.00000M -1719.00000M -535.00000M 253.00M 784.00M
Stock based compensation 276.00M 191.00M 289.00M 264.00M 255.00M
Other non cash items 363.00M 346.00M 1177.00M 264.00M -245.00000M
Free cash flow 3174.00M 4552.00M 6765.00M 7247.00M 7277.00M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
ELV
Elevance Health Inc		 2.62 0.63% 418.15 13.02 12.47 0.36 1.60 0.47
UNH
UnitedHealth Group Incorporated		 7.10 1.78% 406.57 22.57 18.38 1.33 5.65 1.38 13.97
CVS
CVS Health Corp		 1.15 1.20% 97.08 55.65 10.80 0.25 1.32 0.42 17.09
CI
Cigna Corp		 0.13 0.04% 289.61 12.47 9.12 0.27 1.75 0.35
HUM
Humana Inc		 5.90 1.69% 355.98 19.16 14.60 0.56 3.37 0.53

Reports Covered

Stock Research & News

View All

Profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Elevance Health Inc

220 Virginia Avenue, Indianapolis, IN, United States, 46204

Key Executives

Name Title Year Born
Ms. Gail Koziara Boudreaux Pres, CEO & Director 1961
Mr. John Edward Gallina Exec. VP & CFO 1960
Ms. Gloria Marie McCarthy Exec. VP & Chief Admin. Officer 1953
Mr. Peter David Haytaian Esq. Exec. VP and Pres of Diversified Bus. Group & IngenioRx 1970
Ms. Felicia Farr Norwood Exec. VP & Pres of Gov. Bus. Division 1960
Mr. Scott Wayne Anglin SVP, Treasurer & Chief Investment Officer NA
Mr. Ronald William Penczek Sr. VP, Controller & Chief Accounting Officer 1965
Mr. Anil Bhatt Chief Technology Officer NA
Mr. Stephen Vartan Tanal C.F.A. VP of Investor Relations NA
Mr. Blair Williams Todt EVP, Chief Legal Officer and Interim Head of HR, Global Security & Safety Team 1968

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.